Loading clinical trials...
Loading clinical trials...
Injection of Autologous CD34-Positive Stem Cells for Neovascularization and Symptom Relief in Patients With Severe Intermittent Claudication
Conditions
Interventions
Autologous Stem Cells (CD34+)
Locations
2
United States
Cardiology, PC
Birmingham, Alabama, United States
Northwestern University
Chicago, Illinois, United States
Start Date
April 1, 2006
Primary Completion Date
December 1, 2012
Last Updated
March 31, 2015
NCT06212271
NCT07283289
NCT05628948
NCT04794530
NCT03622359
NCT06605209
Lead Sponsor
Losordo, Douglas, M.D.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions